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ABSTRACT 
Objective 
Neurobehavioural disability (NBD) after acquired brain injury (ABI) is often associated with poor 
outcome. The ‘St Andrew’s-Swansea Neurobehavioural Outcome Scale’ (SASNOS) was developed to 
measure NBD in a range of applications. Two of the ‘holy trinity’ of psychometric properties, 
reliability and validity, have been comprehensively mapped, but the extent to which SASNOS meets 
the third, responsiveness, has not been investigated. Demonstrating responsiveness is essential in 
instruments employed in repeated measurement scenarios to confirm their ability to discriminate 
real change from error. However, there is no single agreed method for determining responsiveness. 
For some instruments this property remains unexplored. A difference in scores attaining statistical 
significance for aggregate data is frequently cited as support for this construct, but this approach 
remains heavily criticised. This study explores responsiveness of SASNOS. 
Method 
Consecutive SASNOS assessments completed over varying times for 145 individuals participating in 
neurobehavioural rehabilitation, drawn from multiple services, were compiled into a retrospective 
sample of convenience. Multiple methods were employed to confirm internal responsiveness, 
including those identifying statistically significant change, minimally detectable change and 
minimally important change. 
Results 
All methods confirmed responsiveness as a psychometric property of SASNOS; the extent depended 
on method used and NBD domain investigated. A number of indicators are presented which equip 
clinicians and researchers with options to interpret results from repeated assessments, including the 
individual level in the context of rehabilitation. 
Conclusions 
SASNOS reliably measures change over time in NBD symptoms, further confirming its suitability as 
an instrument for investigating multidimensional outcomes of ABI. 
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INTRODUCTION 
Neurobehavioural disability (NBD) is the product of interactions between damaged neural systems 
and neurocognitive functions, further modified by premorbid personality traits and post-injury 
learning (Wood, 2001). It comprises elements of executive and attentional dysfunction, labile mood, 
altered emotional expression, poor impulse control, poor insight, problems of awareness and social 
judgement, and a range of personality changes that impede psychosocial recovery (Kreutzer 
Marwitz, Seel and Serio, 1996). Behaviour disorders associated with NBD are enduring (Kelly, Brown, 
Todd and Kremer, 2008) and impose serious long-term social handicap (Burke, Wesolowski and 
Lane, 1988; Alderman and Wood, 2013). Fortunately, post-acute neurobehavioural rehabilitation 
(NbR) has shown that many behaviour problems can be ameliorated to reduce their psychosocial 
impact (Wood, Alderman and Worthington, in press).  There is now a good evidence base that 
demonstrates efficacy of NbR programmes, at the level of the individual case, group and service 
level, both clinically and economically (see for example Ylvisaker, Turkstra, Coehlo, Yorkston, 
Kennedy, Moore et al, 2007; Alderman and Wood, 2013; Alderman, Knight and Brooks, 2013; 
Worthington, Matthews, Melia & Oddy, 2006; Oddy and da Silva Ramos, 2013; Wood, McCrea, 
Wood & Merriman, 1999 ). However, in order for NbR to successfully target these behaviours, 
reliable and valid methods of assessing them must first be available.  
 
The ‘St Andrews – Swansea Neurobehavioural Outcome Scale’ (SASNOS) was developed to meet this 
need (Alderman, Wood and Williams, 2011). Underpinned by the World Health Organisation 
International Classification of Functioning, Disability and Health, the SASNOS has robust 
psychometric properties, inter-rater and test-retest reliability has been established, and multiple 
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indicators of validity have been demonstrated. Recent research has also demonstrated that SASNOS 
is able to capture the impact of context on ratings, aiding short-term goal setting and clinical 
decision making (Alderman, Williams and Wood, submitted). However, whilst two of the ‘holy trinity’ 
of psychometric properties of outcome measures, reliability and validity, have been 
comprehensively mapped, the extent to which SASNOS meets the third, responsiveness, has yet to 
be determined.  
 
Broadly defined, responsiveness is the ability to detect change when it has occurred. It has two 
major aspects: 1) ‘external’ responsiveness, which reflects the extent to which change in a measure 
relates to corresponding change in a standard health status measure; and 2) ‘internal’ 
responsiveness, which characterises the ability of a measure to detect change over a pre-specified 
time frame.  The latter aspect of responsiveness is therefore particularly important to consider when 
standardised outcome measures are used in repeated measures contexts, such as NbR.  Whilst it 
may be relatively easy to determine a statistically significant change in scores over time, determining 
when this indicates a clinically meaningful change is more difficult. Indeed, because of its partial 
dependency on sample size, statistical significance does not always correspond to the clinical 
relevance of the observed effect (de Vet, Terwee, Ostelo, Beckerman, Knol and Bouter, 2006; Eisen, 
Ranganathan, Seal and Spiro, 2007). For this reason, determining the extent an instrument measures 
change over time not attributable to error, versus its ability to capture change that is clinically 
meaningful, has heavily influenced investigations of internal responsiveness. In turn, this has 
resulted in two main approaches to determining the smallest amount of change on a measure over 
time that is likely to be of importance.  
 
The first is Minimally Detectable Change (MDC), which refers to the smallest difference between 
scores at Time 1 and Time 2 (T1 – T2) that falls outside the measurement error of an instrument 
(Terwee, Dekker, Wiersinga, Prummel and Bossuyt, 2003).  Two main methods of calculation fall 
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under MDC. The first is Standard Error of Measurement (SEM) where differences between T1 and T2 
smaller than one SEM are considered a consequence of error rather than real change. The second is 
MDC confidence intervals. This is where confidence intervals (typically 90-95%; Copay, Subach, 
Glassman, Polly and Schuler, 2007; Donoghue and Stokes, 2009; Walton, Macdermid, Nielson, 
Teasell, Chiasson and Brown, 2011) can be constructed around SEM to further inform judgements 
regarding the minimum difference in scores that is not a result of measurement error within a given 
level of assurance. Absolute reliability from a statistical perspective is determined from the SEM, 
whilst MDC provides a means of applying a degree of certainty in the clinical context that a change in 
scores is not attributable to measurement error. However, whilst MDC is useful for contexts where 
assurance is needed that any difference in scores in unlikely to be attributable to error within an 
instrument, it does not necessarily equate to meaningful and important change.  
 
Minimally Important Change (MIC) is used for this purpose and can be defined as “(the difference in 
score) that corresponds to the smallest change in status that stakeholders (persons, patients, 
significant others, or clinicians) consider important” (Eisen, Ranganathan, Seal and Spiro, 2007; 
p.273). As with MDC, there are multiple methods to determine MIC. These include distribution-
based methods that utilise the statistical characteristics of a sample; anchor-based methods which 
compare change in scores with a minimal important change defined on an objective (for example, 
change in medication usage, change in access to health services); subjective methods (for example, 
patient self-report on a global health measure), and the Delphi method, where a panel of experts 
reach consensus on what constitutes MIC following several rounds of consultation. However, each 
approach is not without limitations (Walters and Brazier, 2003), leading to the suggestion that 
distribution-based methods should be used alongside a meaningful exterior anchor wherever 
possible (Wyrich, Tierney, Babu, Kroenke and Wolinsky, 2005).   
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However, identifying an external anchor in the context of NbR can be difficult. First, a single health 
related measure will almost certainly fail to adequately capture the complexity of ABI. Second, lack 
of homogeneity within ABI and the presence of impairment from multiple sources, not just 
behaviour, complicate interpretation of the impact of change between different measures. Third, 
variable insight and awareness undermines validity of self-report, weakening any anchor derived 
from patients in rehabilitation. Fourth, discharge from rehabilitation may provide an external anchor 
testifying to reduction of NBD; however, multiple reasons influence discharge, not just remediation 
of NBD so using this may result in error. Finally, in ABI studies where data has been harvested from 
convenience samples, availability of additional variables which may constitute anchors may be 
limited.  To overcome these difficulties, researchers exploring relationships between distribution-
based approaches and MIC (as defined using external anchors) have proposed using the following 
thresholds to determine proxy indicators of meaningful change. 
 
Standard Error of Measurement: Various threshold values of the SEM of changes in scores in stable 
reference groups have been shown to correspond with MIC (Rai, Yazdany, Fortin and Avina-Zubieta, 
2015), with a SEM of 1 advocated as the minimum that reflects this criterion (Wyrwich and Wolinsky, 
2000; Wyrwich, Tierney and Wolinsky, 1999; Wyrwich, Nieraber, Tierney and Wolinsky, 1999). 
 
0.5 Standard deviation (0.5 SD): In a systematic review of thirty-eight studies for health-related 
quality of life instruments, Norman, Sloan and Wyrwich (2003) found that MIC estimates were close 
to one half of a SD in all but 6 studies. On this basis, they argued that 0.5 SD could be used in most 
circumstances to determine meaningful change.  
 
Standardised Response Mean (SRM): Originally proposed by Cohen, Effect Size (ES) has been 
frequently used to determine responsiveness in clinical investigations conducted in a repeated 
measures context. Most relevant here is the standardised response mean (SRM), a version of ES 
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applicable within groups where change scores for the same individuals at T1-T2 are of interest. The 
magnitude of the size of the effect is determined by applying cut-off thresholds: <20 ‘trivial’; ≥20 to 
<50 ‘small’; ≥50 to <80 ‘medium’; ≥80 ‘large’ effect size. However, Middel and van Sonderen (2002) 
note that the strength of the correlation between T1 and T2 varies between samples in repeated 
measures designs. Consequently, application of ES thresholds at the levels proposed by Cohen may 
lack validity, as variable correlation size results in over or underestimation of classification of the size 
of the effects. Instead, Midell and von Sonderen suggest applying an additional calculation to 
calibrate thresholds according to the size of the T1-T2 correlation, and Norman, Sloan and Wyrwich 
(2003) recommended that a ‘medium’ ES corresponds to clinically meaningful change when using 
SRM as a proxy measure of MIC.  
 
However, despite the availability of these methods, internal or external responsiveness is still not 
habitually investigated in ABI. For example, in a review of ABI tests, scales and questionnaires, Tate 
(2010) found no corresponding information for responsiveness for 10 out of 27 instruments 
reportedly measuring NBD or related symptoms. In addition, in studies of measures where 
responsiveness was investigated, most utilised statistical significance (31.8%) or ES (27.2%) alone, or 
a combination of the two methods (41%).  In light of this, the aim of the current study was to 
comprehensively map the internal responsiveness of the SASNOS because it is routinely used to 
assess response to rehabilitation and this had not been determined previously.  Information about 
this psychometric property is essential in order to properly interpret any variance in scores arising in 
the context of repeated measurement. Specifically, the study sought to (a) determine whether 
SASNOS has the statistical properties to effectively measure expected change in symptoms of NBD 
over time; (b) identify cut-off scores for clinicians and researchers to employ across a range of 
contexts to reliably discriminate genuine improvement from those due to error in the instrument. A 
number of distribution-based methods were employed to meet the study objectives because of lack 
of consensus surrounding the conceptualisation and assessment of responsiveness, (see the 
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recommendations of Wyrwich, Tierney, Babu, Kroenke and Wolinsky 2005), and difficulty 
determining an external anchor in the context of NbR. 
 
METHOD 
Participants 
An anonymous database containing ABI outcomes for 542 participants in residential NbR 
programmes across the UK was consulted. The database was originally compiled as part of a larger 
multisite study investigating time of onset and types of NBD arising from ABI. It contained data from 
a basket of ABI outcome measures, including the SASNOS, as well as some standardised 
demographic and clinical information. All assessments contained on the database were undertaken 
as part of routine clinical practice and completed by the clinical team responsible for the delivery of 
each participants NbR programme.  
 
Participants were included in the current study if the outcomes of two consecutive (T1 and T2) 
SASNOS assessments were available. 145 participants met this criterion, of whom 71% were male. 
There were multiple causes of ABI: trauma (44%), cerebral anoxia (17.1%) and cerebrovascular 
accident (15.6%) comprised the majority, accounting for over 75% of all cases. Mean age at injury 
was 42.5 years of age (SD = 18.2, range 4.7-78.8) and on admission 46.2 years of age (SD = 14.8; 
range = 14-79). Mean time since injury at T1 was 40.9 months, although there was significant 
variability (SD = 10.5, range = 0-516).  Time spent in rehabilitation at T1 was also variable as the 
sample included both acute rehabilitation and long-stay, slow-stream rehabilitation care pathways 
(mean = 45.9 weeks, SD = 52.3, range 1.30 – 339.9). Consequently, and as could be expected, the T1-
T2 time interval was not standardised, although 75% of participants were rated at T1-T2 within twelve 
months. No significant gender differences were found on any of these variables.  
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Ethical approval for the study was granted by NRES Committee East Midlands - Leicester (reference 
11/EM/0283). 
 
Measures  
The St Andrews-Swansea Neurobehavioural Outcome Scale (Alderman, Wood and Williams, 2011):  
This consists of 49-items that capture five major domains of NBD (interpersonal behaviour, 
cognition, aggression, inhibition and communication), each with 2-3 subdomains.  Each item 
consists of a statement regarding a feature of NBD whose perceived prevalence is rated 
using a seven point scale (‘never’ to ‘always’). Ratings are based on observations of the 
person being assessed over a two week period. A major strength of SASNOS over existing 
measures of NBD is availability of normative data from a moderate sized group of 
neurologically healthy controls. Total rating scores pertaining to the measure as a whole, 
five domains and 12 subdomains, are transformed to standardised scores derived from the 
T-distribution, with a mean of 50 and standard deviation of 10 enabling meaningful 
comparison between categories of NBD symptoms, and  the general population. 
Transformations are constructive, so higher scores reflect greater independence. The 
SASNOS has known psychometric properties, sufficient items to capture the diverse range of 
NBD signs and symptoms, satisfactory test-re-test (0.82-0.96) and inter-rater reliability 
(0.59-0.83), and multiple indicators of validity have been demonstrated. However, as stated 
earlier, responsiveness has not been investigated to date.  
 
Total sum of ratings from the SASNOS, and those for each of the five domains, were transformed to 
T-scores. First, for each rehabilitation participant a Z-score was calculated for the five domains and 
overall sum of ratings by subtracting their individual sum of ratings from the mean for neurologically 
healthy controls and dividing the result by the standard deviation for neurologically healthy controls 
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(see table XIII, p94, Alderman, Wood and Williams, 2011). Second, individual T-scores were obtained 
in the usual way (𝑇 = 50 + 10𝑧). It is these T-scores that are reported in the subsequent evaluation 
described here.  
 
A further point of relevance regarding scores for this investigation is the distinction between those 
who present with symptoms of NBD that are atypical of those observed in the neurologically healthy 
population. The number of standard deviations from the mean provides one method of highlighting 
potential areas of concern. Whilst scores in excess of 2 SD from the mean have statistical 
significance, those exceeding 1 SD also have been advocated within neuropsychology as being 
clinically of interest (Heaton, Grant and Matthews, 1991). In an earlier SASNOS study, Alderman, 
Wood and Williams (2011) demonstrated cut-off scores based on one (40) and two (30) SD 
discriminated between neurologically healthy and ABI participants. For example, 86% of 
neurologically healthy controls achieved a total score of more than 40 and 92% greater than 30. In 
contrast, nearly all people with ABI achieved a total T-score that fell below 40, whilst 77.9% achieved 
scores below 30. As these results suggest NBD is highly atypical of neurologically healthy people, and 
highly characteristic of ABI, the recommendation of the authors was that T- scores less than 40 
should be considered exceptional and consequently an indicator for potential rehabilitation goals. 
 
Data Analysis  
To determine the responsiveness of the SASNOS, data was analysed using the following methods:    
1. Statistical significance: Paired sample t tests were performed to compare SASNOS ratings at T1 
and T2 (alpha level p<.05).  
2. Minimally detectable change: SEM was obtained from 𝑆𝐷 × √(1 − 𝐼𝐶𝐶) ((Rehabilitation Institute 
of Chicago, 2010). SD was from T1, and ICC the reliability estimate of the test, in this case the 
consistency intra-class correlation of SASNOS scores over time, as calculated and reported by 
Alderman, Wood and Williams (2011). MDC at the 90th confidence interval (MDC90) was derived from 
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𝑆𝐸𝑀 × 1.65 × √2. In this equation, 1.65 is the z-score at the 90th confidence level, and the square 
root of 2 is used as a multiplier to account for error associated with repeated measurements (Hayley 
and Fragala-Pinkham, 2006; Stratford, 2004). Similarly, substituting 1.65 with 1.96 gives MDC at the 
95th confidence level (MDC95) 𝑆𝐸𝑀 × 1.96 × √2. 
 
3. Minimally important change proxies: SEM was calculated as above. The 0.5 SD proxy MIC was 
derived using the standard deviations for the six SASNOS scores at T1 (Norman, Sloan and Wyrwich, 
2003). SRM was derived by dividing the T1-T2 mean change score by the SD of that change score 
(𝑥 ̅  𝑐ℎ𝑎𝑛𝑔𝑒)/(𝑆𝐷 𝑐ℎ𝑎𝑛𝑔𝑒). 
 
4. Categorising the extent of change: Following the criteria adopted by Eisen, Ranganathan, Seal and 
Spiro (2007), participants were categorised on the four distribution-methods as being ‘improved’, 
‘same’ or ‘declined’. For SEM, participants were classed as ‘improved’ if the T1 – T2 difference 
exceeded 1 SEM, ‘same’ if the difference was less than 1 SEM, and ‘declined’ if it fell more than 1 
SEM. The same method was used to categorise participants for MDC and 0.5 SD. In the case of SRM, 
participants were defined as ‘improved’ if recalibrated SRM values were ‘moderate’ or more using 
𝑆𝑅𝑀 ≥ 0.50, ‘same’ for −0.50 ≥ 𝑆𝑅𝑀 < 0.50, and ‘declined’ when 𝑆𝑅𝑀 ≤ −0.50. (Cohen, 1988; 
Eisen, Ranganathan, Seal and Spiro, 2007). 
 
5. Agreement between MDC methods: The weighted kappa statistic was used to determine levels of 
agreement between the distribution-based methods and the proportion of participants categorised 
as ‘improved’, ‘same’ and ‘declined’ at T2 compared to baseline scores at T1 as a consequence of the 
criteria described above. Weighted kappa was employed following the precedent using an identical 
methodology described by Eisen and colleagues (2007). In both studies, results of distribution-based 
methods were employed to populate categorical items and kappa provides an appropriate statistic 
for this purpose. Weighted kappa was utilised to take into account that categories are ordered and 
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to reflect the extent of any disagreement arising from classification using scores from the five 
distribution-based methods. 
Statistical analysis was undertaken using SPSS v22 (IBM Corp., 2013), with the exception of weighted 
kappa values which were calculated using MedCalc v16.8 (MedCalc Software, 2016). 
 
RESULTS 
Aggregate change over time 
Summary statistics for SASNOS total and domain scores at T1 and T2 are summarised in table 1, along 
with the results of statistical significance testing and magnitude of effect size (SRM). 
 
< TABLE 1 ABOUT HERE > 
 
With the exception of ‘Aggression’ domain scores, paired samples t-tests revealed highly significant 
(p<.002 or better) increases in SASNOS total and domain scores from T1 to T2.  Differences in mean T-
scores varied from 8.32 scale points (‘Cognition’) to 1.27 (‘Aggression’). However, the magnitude of 
effect size, as calculated using SRM, varied across SASNOS domains. Consistent with the result from 
the t test, a ‘large’ effect size was found for ‘Cognition’. In contrast, the size of the effect was 
‘medium’ for the total SASNOS score and ‘Interpersonal Behaviour’ domain; and ‘small’ for the 
remaining three domains. Whilst there was no statistically significant difference between mean T-
scores for ‘Aggression’, lack of convergence between this method and SRM is evident from the 
‘small’ effect size for ‘Inhibition’ and ‘Communication’ despite highly statistically significant 
differences (p=.002 and p<.001 respectively).   
 
Values achieved for the MDC and MIC measures for SASNOS total and domain scores are shown in 
table 2. Table 3 summarises the percentage of participants whose T1 – T2 scores suggest differences 
in ratings above what would be considered a consequence of error within the instrument or 
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individual variability (MDC - SEM, MDC90, MDC95). Table 3 also shows the percentage of participants 
who exceeded a responsiveness threshold found in other studies to equate to important, meaningful 
change (MIC proxies - SEM, 0.5 SD, SRM). 
 
< TABLES 2 & 3 ABOUT HERE > 
 
The percentage of participants whose T1 – T2 scores indicate real change rather ranged from 32-64% 
based on SEM, 14-46% based on MDC90, and 12-44% based on MDC95. As both MDC methods are 
confidence intervals are derived from the SEM, it is not surprising that SEM identified the most 
individuals as achieving scores that fall above the minimum required for absolute reliability. Using 
SASNOS total scores, just over half the sample showed a reduction in symptoms of NBD at T2 based 
on SEM, and just over a third based on both MDC90 and MDC95. ‘Cognition’ domain scores showed 
the greatest change using all three methods (44.1 – 64.8%), and the least change was observed for 
‘Inhibition’ domain scores based on MDC (14.5 and 12.4%) and ‘Aggression’ scores based on SEM 
(32.4%). 
 
Across all SASNOS scores, the proportion of participants showing clinically meaningful improvement 
ranged from 32-64% for SEM, 24-46% for 0.5 SD, and 27-54% for SRM. SEM categorised the largest 
percentage of participants as having achieved minimally important change at T2 using SASNOS total 
scores (53.1%), followed by SRM (46.9%) then 0.5 SD (40.7%). SEM also identified the greatest 
proportion of participants as meaningfully improved using SASNOS domain scores (see Table 3). 
With the exception of ‘Inhibition’ domain scores, SRM categorised the lowest percentage. Across all 
three methods, the domain showing the most change from T1 – T2 was ‘Cognition’ (46.2-64.8%), with 
‘Aggression’ showing the least (24-32%).  
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Discriminating rehabilitation participants expected to make the most change 
Examination of table 1 indicates that the smallest difference between means and smallest effect 
sizes were evident on the ‘Inhibition’, ‘Aggression’ and ‘Communication’ domains, with overall mean 
T-scores at T1 falling above the normative reference mean (50). In contrast, mean SASNOS total, 
‘Interpersonal Relationships’ and ‘Cognition’ scores fell more than one SD below the reference 
mean. Consistent with the non-homogeneous nature of ABI, this finding suggests that some 
symptoms of NBD are more endemic than others. In addition, people in the current sample were 
rated at different times in their rehabilitation journey, and therefore assessment at T1 may reflect a 
reduction of NBD symptoms from admission.   
 
Consequently, the responsiveness data described above may be better scrutinised by applying 
criteria to discriminate at T1 between participants whose domain scores suggest an absence of 
problematic behaviour, versus those whose scores fall one SD or more below the mean for 
neurologically healthy controls (e.g., a domain score of less than 40 at T1), thus suggesting the 
presence of NBD. The assumption tested by categorising participants in this way is that participants 
whose SASNOS scores suggest NBD symptoms are problematic at T1 should show greater 
responsiveness than those which are more characteristic of the general population, given the 
reported efficacy of NbR programmes. Therefore, it was predicted that the proportion of 
participants exceeding the multiple thresholds reflecting both MDC and MIC for T1-T2 will be higher 
for participants with domain scores of less than 40 at T1 than for those whose scores are equal to or 
greater than 40. 
 
Discriminating participants into different groups is widely reported in the responsiveness literature. 
A ‘control’ group is sometimes utilised directly for comparison purposes with an intervention or 
treatment group; it is also used to generate statistics that are then utilised in the calculation of 
certain responsiveness indices. A control group does not necessarily employ healthy individuals 
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drawn from the general population.  In other studies, clinical subjects are employed for these 
purposes when they are stable or otherwise not expected to change (Walters and Brazier, 2003; Rai, 
Yazdany, Fortin and Avina-Zubieta, 2015). Given lack of homogeneity within the ABI population and 
the variable proportions of individuals presenting with symptoms of NBD, as measured by the 
SASNOS, there was no expectation that all rehabilitation participants would necessarily present at T1 
with symptoms of all these, either because they have not been a feature of their post-injury 
presentation or have already been positively remediated by NbR received to date. In this case, 
discriminating between participants in this way advantages the analysis in two ways.  Firstly, for 
comparison reasons, contrasting differences in T1-T2 scores; secondly, and more importantly, 
enhancing calculation of responsiveness indices by targeting participants in which change is 
expected. 
 
< TABLE 4 ABOUT HERE > 
 
Results of categorising participants are shown in table 4. This confirms the assumption that 
responsiveness is most evident amongst those whose SASNOS assessment suggests NBD symptoms 
are more prolific than the general population. In all the comparisons made, a greater percentage of 
participants with a T1 score of less than 40 achieved a T1-T2 difference that exceeded thresholds for 
responsiveness across all the methods used on SASNOS total and domain scores. This finding is 
consistent with the hypothesis that those participants whose scores suggested they will benefit the 
most from NbR do so. 
 
In relation to MDC methods, SEM categorised the most people who were expected to improve as 
improving (63-77%). For those rated in the normal range or higher at T1, 25-44% achieved a 
difference in ratings at T2 greater than the SEM threshold for MDC. As expected, both MDC90 and 
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MDC95 provided more conservative results. 37-61% of those expected to improve did so based on 
MDC90, whilst 37-55% were categorised as having done so based on MDC95. 
  
Of the three proxy indicators of MIC, the SEM method also classified the highest percentage of 
participants (63-77%). The 0.5 SD method categorised 47-66% as making important, meaningful 
change in cases where initial SASNOS scores were less than 40, with 18-29% improved who were in 
the normal range or higher at T1. The SRM method classified 54-66% expecting to improve as 
subsequently doing so, with 16-42% of those whose scores suggested symptoms of NBD were in the 
expected range at first assessment also making improvement. 
 
Finally, magnitude of the size of the effect was examined by calculating SRM’s for the group 
expected to show the most change, comparing them to the values obtained for the whole sample. 
Higher adjusted SRM’s were evident for four of the six SASNOS scores in the reduced sample. With 
regard to classification of the magnitude of the size of the effect, this remained unchanged for the 
total score (‘moderate’: .57 vs. .71), ‘Interpersonal Behaviour’ (‘moderate’: .75 vs. .67) and 
‘Cognition’ (‘large’: .92 vs. .91). However, whilst the magnitude of the effect size was originally 
‘small’ for the remaining thee SASNOS domains when all cases were considered, this became ‘large’ 
when cases expected to show the most potential for change were considered separately 
(‘Inhibition’: .26 vs. .82; ‘Aggression’: .15 vs. 1.05; ‘Communication’: .40 vs. .93). 
 
Agreement among methods 
Agreement among the five distribution-based methods varied across SASNOS total and domain 
scores (see table 5). Regarding total score, weighted kappas ranged from .50-.95 (‘moderate’ to 
‘almost perfect’ agreement). Agreement between domain scores was also variable, ranging from .40-
.89 for ‘Interpersonal Behaviour’, ,36-.98 for ‘Cognition’, .26-1.00 for ‘Inhibition’, .58-.92 for 
‘Aggression’ and .33-1.00 for Communication. Agreement was more consistent between the three 
Page 17 
 
MIC methods, ranging from .66-.83 for total SASNOS scores, .78-.81 for ‘Interpersonal Behaviour’, 
.47-.70 for ‘Cognition’, .85-1.00 for ‘Inhibition’, .80-90 for ‘Aggression’ and .73-1.00 for 
‘Communication. 
 
< TABLE 5 ABOUT HERE > 
 
Possible effects of variability within the sample on the results obtained 
As noted, some variability was evident within the sample of convenience utilised for this study and 
possible effects of this on the results were explored. Firstly, there was no evidence that the amount 
of NbR provided, based on the length of time spent in neurobehavioural rehabilitation between T1-
T2, was related to the amount of change observed through differences on the SASNOS total score, 
and scores on each of the five domains (Pearson correlations ranged from -.04 to .17). Similarly, the 
extent of NBD symptoms measured at T1 was not found to be related to how much time had elapsed 
since injury. For each of the six SASNOS scores, rehabilitation participants were categorised into two 
groups using the criteria specified before (T-score < 40 vs. T-score ≥ 40). Using independent t-tests, 
there were no between-group differences for mean time since injury, age at injury and length of stay 
up to T1 (p >.05). Age on admission did not discriminate between the two groups with the exception 
of ‘Aggression’.  Rehabilitation participants who scored below 40 on this domain were younger on 
admission (mean age = 38.6 years, SD = 14.6) than those rated within the expected range or higher 
for neurologically healthy controls (mean age = 47.4 years, SD = 14.7; t = 2.36, p = .02). 
 
DISCUSSION 
The overarching goal of this study was to investigate internal responsiveness of the SASNOS which 
had previously remained unexplored. In previous studies of health-change related instruments, 
multiple methods have characteristically taken the form of examining change in repeated 
measurements relative to change in an external anchor, most typically a general measure of physical 
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or mental health, or quality of life. In this study, an appropriate external anchor could not be 
identified and thus, internal responsiveness was examined. A lack of a ‘gold standard’ or universally 
accepted methodology for determining internal responsiveness resulted in several methods being 
employed, including methods examining statistical significance of change between repeated SASNOS 
scores, identifying change beyond that associated with error, and ascertaining important and 
meaningful change. 
 
The first aim of the study was to determine whether the SASNOS has the statistical properties to 
effectively measure expected change in symptoms of NBD over time. Using a sample of participants 
in residential NbR, responsiveness was demonstrated using multiple methods. Although this varied 
according to the method used and the SASNOS score considered. Consistent with previous literature 
(de Vet, Terwee, Ostelo, Beckerman, Knol and Bouter, 2006; Eisen, Ranganathan, Seal and Spiro, 
2007) methods examining statistical significance of change between repeated SASNOS scores were 
of limited value.  Indeed, although the current sample size was not very large, comparatively small 
differences between means nevertheless resulted in very high significance levels using paired 
samples t tests. In addition, it’s unclear how the results of the tests of statistical significance map 
onto real change, or can be applied to understand magnitude of change in scores on an individual 
level. Consequently, five other distribution based methods were used to further inform clinicians 
and researchers about internal responsiveness as a psychometric property of the SASNOS, and 
provide better information regarding the meaning of any change in ratings between assessments. 
 
The second aim of the study was to determine the magnitude of change from T1 – T2 to determine 
what aspects of NBD are most amenable to NbR. Magnitude of the size of effects calculated 
suggested that a ‘moderate’ reduction in NBD symptoms was achieved across the sample overall, 
with between a third and a half of participants exceeding change thresholds.  For example, a 
‘moderate’ reduction in interpersonal problems was found, which is unsurprising given existing 
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evidence of the effectiveness of NbR for the management of social behaviours.  However, a more 
surprising finding was that the greatest change in scores was found in the ‘Cognition’ domain (44-
64% improving), despite the belief that neurocognitive functions tend to be fixed or static in samples 
participating in NbR many years beyond the time in which spontaneous recovery is expected.  In 
addition, even though the literature emphasises that referrals to NbR services are often driven by 
challenging behaviour associated with lack of inhibition and aggression, effect sizes for these 
SASNOS domains were ‘small’ (ranging from 14-43%, less than half the sample). An explanation for 
this apparent anomalous finding rests in the lack of consistency in the time at which T1 was 
administered. Few participants in the current sample were initially assessed on admission, when 
these challenging behaviours might have been most apparent; and given the known effectiveness of 
NbR in managing difficulties with inhibition and aggression, by T1 rehabilitation may already have 
succeeded in reducing symptoms associated with these domains. This explanation is partially 
supported by the analysis in which responsiveness was determined for rehabilitation participants 
with SASNOS scores below the level associated with neurologically healthy controls. When this was 
done, the size of the effect for the ‘Inhibition’, ‘Aggression’ and ‘Communication’ domains increased 
from ‘small’ to ‘large’. For example, with regards to aggression, 55-77% of rehabilitation participants 
expected to make the most change did so, compared to only 18-32% in the sample as a whole. In 
addition, across all domains and methods, more people improved who were expected to improve 
than those whose symptoms were in the normal range for neurologically healthy controls at T1. 
 
These findings suggest that the effectiveness of NbR as assessed using SASNOS extends across all 
symptom domains, with perhaps the greatest challenge being the remediation of NBD symptoms 
observed in the context of social interaction and relationships. It also suggests that examination of 
responsiveness needs to be conducted in a targeted way, by considering participants who are 
expected to benefit. The cut-off score of 40 used in the current study provides clinicians with one 
means of discriminating in this way. A future study which synchronised SASNOS assessments so they 
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captured NBD on admission and regular intervals thereafter would clarify the relative speed in which 
the different domains are successfully targeted. Even so, on the basis of the current findings, we 
advocate that NbR is effective across all major categories of NBD as captured by the SASNOS. 
 
The final goal was to identify cut-off scores that would allow clinicians and researchers to reliably 
discriminate between differences in SASNOS scores that indicate genuine improvement rather than 
error in the instrument. A range of indicators were identified that could be used for this purpose 
(table 2), depending on the questions asked. For example, researchers requiring higher confidence 
levels to determine numbers of people responding using cohort data may be drawn to MDC, as the 
principal need will be to ensure discrimination of cases whose difference scores exceed thresholds 
for error. When the question asked necessitates specifying an overall index of the magnitude of 
change, SRM would be appropriate. SRM is simple to calculate using repeated SASNOS assessments 
and the magnitude of the effect size determined using Middel and van Sonderen’s (2002) solution. In 
contrast, when the main goal is to determine individual change in scores, less conservative 
thresholds may be appropriate, especially in a clinical context. Although there was high agreement 
between the three MIC methods regarding categorisation of the extent of change, SEM identified 
the highest proportion of individuals in the sample as improved, a finding that is consistent with 
other studies of responsiveness of health related outcome measures (Eisen, Ranganathan, Seal and 
Spiro, 2007). Therefore, for evaluating change in SASNOS scores for clinical purposes, SEM is 
recommended for the following reasons. First, it has previously been argued SEM is a better method 
for determining MIC because it is independent of SD; consequently, it does not vary between 
samples and provides a more stable method for determining meaningful change (Wyrwich and 
Wolinsky, 2000; Eisen, Ranganathan, Seal and Spiro, 2007). Second, the SEM criterion has been 
widely reported in the assessment of MIC in individuals with both chronic medical and mental health 
conditions, and long-term behavioural issues (Hays, Brodsky, Johnston, Spritzer and Hui, 2005; 
Wyrwich, Tierney and Wolinsky, 1999; Eisen, Ranganathan, Seal and Spiro, 2007); as outcome from 
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ABI is also associated with long-term impairment, SEM may be similarly indicated in determining 
change to NBD symptoms. Finally, SEM has been cited as both a method used to discriminate change 
beyond that expected from error, and as a proxy that reflects minimally important change, 
increasing the range of applications and questions regarding change and responsiveness it can 
readily be employed with. 
 
SEM can also be used to determine individual change. Probabilities of the normal curve can be 
applied to SEM values, making it easily applicable in determining the extent to which a difference in 
SASNOS ratings represents meaningful and important improvement (Domholft, 2005; Ries, 
Echternach, Nof and Gagnon Blodgett, 2009). SEM values in table 2 can be used for this purpose: 
there is a 68% probability that a difference in scores on repeated measurement will fall within ±1 
SEM and a 96% probability it will be within ±2 SEM. To illustrate this, an individual rehabilitation 
participant achieving a difference in ‘Interpersonal Behaviour’ scores at repeated assessment of 6 
points exceeds the 68% probability threshold that this is a meaningful change (±3.77, 1 SEM) but not 
at the 96% level (±7.54, 2 SEM). The same participant obtains a difference in ‘Aggression’ scores of 
11 points. As there is a 96% probability that a repeated measure of this domain will be within ±7.16 
(2 SEM), the size of the difference obtained can reasonably be interpreted as representing change 
beyond the expected variability. Also as 1 SEM has been cited as a proxy measure of MIC, criteria for 
attainment of change that is meaningful and important is also met at both the 68% and 96% 
probability levels. Consequently, a difference in repeated measures of more than 2 SEM is likely to 
reflect real variation that is both beyond that associated with error and indicative of meaningful 
change. 
 
However, there are some weaknesses to the current study, principally arising from use of 
retrospective data drawn from a convenience sample, together with suggestions regarding how 
these can be addressed and potential goals for further research. One suggestion concerns the need 
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to identify an anchor to benchmark change in SASNOS against, thus allowing an investigation of 
external responsiveness. The main characteristic this should have is that at T1 it needs to reflect 
access to activities restricted because of NBD, and at T2 a reduction or absence of such restrictions. 
For example, a change in classification on the Supervision Rating Scale (Boake, 1996) that reflects 
increased autonomy (results correspond with the level of supervision required, these being 
independent, overnight, part-time, full-time indirect, and full-time direct supervision). A related 
issue that could also be addressed in this way is that the proxy measures of MIC determined from 
the systematic reviews of the literature were identified using health-related quality of life 
instruments in non-ABI populations. Aligning the size of a difference in repeated SASNOS 
assessments with an independent indicator of meaningful change relevant to ABI will help 
substantiate validity of the current MIC thresholds. 
 
Further points to note are that SASNOS assessments were not synchronised and responsiveness data 
did not cover the entire duration of NbR, only a fixed period within this.  Even so, the current results 
do nevertheless support the effectiveness of NbR in reducing NBD. However, investigating a sample 
in which SASNOS assessments were repeated on admission, at standard intervals thereafter, and at 
discharge, would potentially answer some of the questions asked earlier regarding the overall 
impact of NbR from admission to discharge, particularly regarding aggression, and difficulties with 
inhibition and communication. 
 
Despite variability within the control group regarding timing of SASNOS assessments, analysis did not 
suggest these made a significant impact on the results obtained or conclusions reached. At the level 
of the group, time spent in NbR was not associated with change in NBD symptoms. Although 
detailed information regarding the sample was lacking, there were no obvious differences between 
rehabilitation participants rated as having more symptoms than observed in the general population 
form those that did not (with the exception of the ‘Aggression’ domain where there was a difference 
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in age at admission). However, given that the ABI population is so non-homogenous, including the 
extent of NBD and its multiple drivers, lack of linear relationships between time spent in NbR and 
other factors is not surprising as NbR interventions are necessarily highly configured to meet 
individual needs (Alderman, Knight and Brooks, 2013). 
 
A final point concerns the lack of a reference group at this stage to enable tracking of the natural 
progression of symptoms of NBD amongst people with ABI who are not in receipt of specialist 
rehabilitation using the SASNOS. The existing literature suggests the natural evolution of NBD is 
associated with chronic difficulties. In contrast, reduction of symptoms was evident amongst 
rehabilitation participants, presumably because they were engaged in NbR. Availability of 
responsiveness data confirming the expected deteriorating trajectory evidenced from repeated 
measurement on the SASNOS amongst people with ABI who have not been in receipt of NbR would 
further affirm both the measure and effectiveness of NbR. It is also worthy of note that splitting 
cases within domains into those expected to change the most based on a score of less than 40 does 
provide some extra evidence regarding the approach, as the magnitude of the effect size and 
number of people improving was consistently greater amongst this group as opposed to those with 
NBD symptoms comparable at T1 with neurologically healthy controls. NBR symptoms are also 
evident in the general population and it would be similarly useful to determine base rates of change 
in this group for comparison purposes. 
 
In conclusion, this study presents evidence that SASNOS reliably measures change over time in NBD 
symptoms. This further extends the psychometric properties reported by Alderman, Wood and 
Williams (2011), confirming a role for use of the instrument by clinicians and researchers 
investigating the multidimensional outcomes arising from ABI. 
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TABLES 
 
 T1 T2     
SASNOS 
?̅?1 
(𝑆𝐷) 
?̅?2 
(𝑆𝐷) 
t p 𝑟𝑇1−𝑇2 SRM
1 
Total Score 37.93 
(11.76) 
43.18 
(11.93) 
6.053 <.001 .62 .57 moderate 
Interpersonal 
Behaviour 
26.37 
(14.24) 
34.36 
(14.90) 
7.454 <.001 .66 .75 moderate 
Cognition 21.08 
(13.33) 
29.40 
(15.26) 
8.809 <.001 .69 .92 large 
Inhibition 53.33 
(10.74) 
55.94 
(9.24) 
3.132 .002 .50 .26 small 
Aggression 56.00 
(12.65) 
57.27 
(12.74) 
1.370 .173 .60 .15 small 
Communication 60.86 
(11.42) 
63.53 
(10.91) 
3.724 <.001 .70 .40 small 
Table 1: statistically significant differences in mean SASNOS T-scores and magnitude of effect size 
achieved at first and second assessment [1effect magnitude thresholds adjusted and shown in 
brackets to take into account 𝑟𝑇1−𝑇2 strength using Middel and van Sonderen (2002) solution]. 
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SASNOS MDC90 MDC95  SEM 0.5 SD SRM1 
Total Score 6.66 7.96  2.88 5.88 .57 
Interpersonal Behaviour 8.72 10.42  3.77 7.12 .75 
Cognition 6.17 7.38  2.67 6.67 .92 
Inhibition 10.54 12.60  4.56 5.37 .26 
Aggression 8.28 9.89  3.58 6.33 .15 
Communication 8.76 10.47  3.79 5.71 .40 
Table 2: MDC and MIC proxies calculated for the SASNOS total score and five principal domains 
[1adjusted effect magnitude thresholds shown in brackets]. 
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SASNOS MDC90 MDC95  SEM 0.5 SD SRM 
Total Score 38.6 34.5  53.1 40.7 46.9 
Interpersonal Behaviour 37.9 34.5  59.3 42.8 49.7 
Cognition 46.2 44.1  64.8 46.2 54.5 
Inhibition 14.5 12.4  35.9 28.3 28.3 
Aggression 23.4 18.6  32.4 24.8 27.6 
Communication 17.9 14.5  43.4 30.3 43.4 
Table 3: percent of individuals categorised at T2 as achieving minimal detectable change and 
clinically meaningful improvement on the SASNOS using the various responsiveness measures. 
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SASNOS MDC90 MDC95  SEM 0.5 SD SRM 
Total Score       
< 40 50.0 42.5  63.7 52.5 58.8 
≥ 40 24.6 24.6  40.0 26.3 32.3 
Interpersonal Behaviour       
< 40 43.5 40.0  64.3 47.8 54.8 
≥ 40 18.5 14.8  44.4 25.9 33.3 
Cognition       
< 40 49.3 47.0  68.2 49.3 58.2 
≥ 40 16.7 16.7  33.3 16.7 16.7 
Inhibition       
< 40 37.5 37.5  68.8 56.3 56.3 
≥ 40 11.5 9.2  31.5 24.6 24.6 
Aggression       
< 40 61.1 55.6  77.8 66.7 66.7 
≥ 40 18.0 13.3  25.8 18.8 21.9 
Communication       
< 40 50.0 33.3  66.7 50.0 66.7 
≥ 40 16.2 13.4  41.5 28.9 42.3 
Table 4: percent of individuals categorised at T2 as achieving minimal detectable change and 
clinically meaningful improvement on the SASNOS using the various responsiveness measures. A 
between groups comparison has been added by categorising rehabilitation participants using their T1 
ratings (< 40 = T-score less than 1SD below the normative mean T-score of neurologically healthy 
controls, ≥ 40 = T-score within ±1SD or greater than the normative mean T-score of 50). 
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  Total Score Interpersonal 
Relationships 
Cognition Inhibition Aggression Communication 
  1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
1 SEM                         
2 MDC90 .61    .48    .49    .40    .72    .41    
3 MDC95 .50 .87   .40 .89   .36 .84   .26 .78   .58 .85   .33 .87   
4 0.5 SD .66 .95 .82  .60 .86 .75  .47 .98 .87  .85 .50 .35  .80 .92 .76  .73 .63 .52  
5 SRM .82 .78 .66 .83 .81 .64 .55 .78 .75 .72 .57 .70 .85 .50 .35 1.00 .90 .82 .67 .90 1.00 .41 .33 .73 
Table 5: weighted kappa values showing agreement amongst the five distribution based methods for the total SASNOS standardised score and for each of 
the five domains. 
